We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
+9.4%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$704M
AUM Growth
-$442M
Cap. Flow
-$488M
Cap. Flow %
-69.26%
Top 10 Hldgs %
31.51%
Holding
402
New
6
Increased
57
Reduced
64
Closed
261

Top Buys

Rank Stock Value
1
RMD icon
ResMed
RMD
+$13.4M
2
TOL icon
Toll Brothers
TOL
+$11.4M
3
UNH icon
UnitedHealth
UNH
+$5.17M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.49M
5
SGRY icon
Surgery Partners
SGRY
+$2.55M

Sector Composition

Rank Sector Weight
1 Healthcare 32.95%
2 Consumer Discretionary 18.04%
3 Technology 14.64%
4 Financials 13.2%
5 Industrials 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIG icon
251
Hartford Financial Services
HIG
$37.7B
-6,174
Closed -$430K
HLT icon
252
Hilton Worldwide
HLT
$72.6B
-6,991
Closed -$985K
HON icon
253
Honeywell
HON
$74.6B
-6,017
Closed -$1.08M
HST icon
254
Host Hotels & Resorts
HST
$15.6B
-10,074
Closed -$166K
HSY icon
255
Hershey
HSY
$37B
-2,434
Closed -$619K
HUM icon
256
Humana
HUM
$46.7B
-1,396
Closed -$678K
HXL icon
257
Hexcel
HXL
$7.74B
-16,207
Closed -$1.11M
IBM icon
258
IBM
IBM
$222B
-6,868
Closed -$900K
IFF icon
259
International Flavors & Fragrances
IFF
$21.4B
-3,829
Closed -$352K
ILMN icon
260
Illumina
ILMN
$29.1B
-1,734
Closed -$392K
INCY icon
261
Incyte
INCY
$24.5B
-192,505
Closed -$13.9M
INFY icon
262
Infosys
INFY
$49.7B
-64,000
Closed -$1.12M
INTU icon
263
Intuit
INTU
$91.6B
-1,943
Closed -$866K
IOVA icon
264
Iovance Biotherapeutics
IOVA
$3.05B
-530,452
Closed -$3.24M
IRTC icon
265
iRhythm Holdings
IRTC
$4.13B
-26,112
Closed -$3.24M
ISRG icon
266
Intuitive Surgical
ISRG
$142B
-2,659
Closed -$679K
ITW icon
267
Illinois Tool Works
ITW
$83.3B
-2,059
Closed -$501K
JCI icon
268
Johnson Controls International
JCI
$92.6B
-7,219
Closed -$435K
KEYS icon
269
Keysight
KEYS
$60.6B
-95,522
Closed -$15.4M
KLAC icon
270
KLA
KLAC
$272B
-10,950
Closed -$437K
KMB icon
271
Kimberly-Clark
KMB
$36.2B
-3,988
Closed -$535K
KNSA icon
272
Kiniksa Pharmaceuticals
KNSA
$6.1B
-116,376
Closed -$1.25M
KR icon
273
Kroger
KR
$34.3B
-5,383
Closed -$266K
KURA icon
274
Kura Oncology
KURA
$882M
-113,674
Closed -$1.39M
LIN icon
275
Linde
LIN
$221B
-4,750
Closed -$1.69M

Similar funds

Lombard Odier Asset Management (Switzerland)'s Q2 2023 Portfolio in Review

As of Q2 2023, Lombard Odier Asset Management (Switzerland) held 402 positions worth $704M, down 39% from $1.15B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Lombard Odier Asset Management (Switzerland) withdrew a net $488M in Q2 2023, closing 261 positions and reducing 64 holdings. Its most notable exit was Insulet, an estimated $19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 44% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Lombard Odier Asset Management (Switzerland) opened a new position in ResMed worth $13.2M.

  • Lombard Odier Asset Management (Switzerland)'s largest Q2 2023 buy was ResMed: 60,254 shares worth $13.2M.
  • Lombard Odier Asset Management (Switzerland) added most to UnitedHealth in Q2 2023, an estimated $5.17M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q2 2023 reduction was DexCom, cutting an estimated $21.1M.
  • Lombard Odier Asset Management (Switzerland) fully exited Insulet in Q2 2023, selling an estimated $19M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 32% of its $704M portfolio in Q2 2023.
  • Lombard Odier Asset Management (Switzerland) opened 6 new positions and closed 261 in Q2 2023.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 39% quarter-over-quarter to $704M.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.